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Background 
The WHO has identified Antimicrobial Resistance (AMR) as one of the most significant global 
risks facing modern medicine. Interventions to improve antibiotic prescribing have so far 
had limited impact. 
Aim 
To understand the barriers to effective antibiotic prescribing. 
Methods 
Mixed methodologies were used to investigate prescribing behaviours to identify the critical 
points in the antibiotic prescribing pathway for hospital inpatients. We assessed knowledge, 
experience or empowerment of prescribers, organisational factors and use of the 
laboratory. Phase 1 was an online survey to map barriers and facilitators to antibiotic 
prescribing (56 participants). Phase 2 consisted of focus groups and interviews to gain more 
understanding of prescribing behaviours (10 participants). Phase 3 was an online survey to 
obtain opinions on possible solutions (22 participants). 
Results  
Barriers to prescribing were: laboratory factors 71.6%, resource issues 40%, time constraints 
17.5%, pressure from others 52%. Ninety-three percent of prescribers were concerned 
about AMR. In three scenarios only 9% were confident not to prescribe antibiotics for a 
patient without bacterial infection; 53% would prescribe unnecessarily broad spectrum 
antibiotics for pneumonia. Only 5% would de-escalate antibiotics in a microbiologically-
confirmed bacteraemia.  
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Despite concerns about AMR, prescribers did not perceive continuing antibiotics for 
individual patients might promote resistance. Prescribers were unwilling to change 
antibiotics out of hours and reported they preferred professional support for antibiotic 
prescribing.  
Conclusions 
There was a marked disparity between prescribers self-reporting of prescribing behaviour 
and responses to clinical scenarios. It was not clear whether training alone would change 
behaviours. Prescribers desired a directive mechanism to support antibiotic prescribing and 
stewardship. 
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Introduction  
The emergence of extensively drug-resistant and pandrug-resistant bacteria has been 
identified by the World Health Organization as one of the most significant global risks facing 
modern medicine [1]. In the UK, annual  antibiotic awareness campaigns have been 
promoted since 1999, and in 2011 the `Start Smart - Then Focus’ antibiotic stewardship 
toolkit, that provided an outline of evidence-based antimicrobial stewardship in the 
secondary healthcare setting, was published [2]. Globally, there have been many other 
similar initiatives [1, 3]. However, this emphasis on antibiotic stewardship has so far had 
limited impact on reducing antibiotic use in hospitals. In England, the number of antibiotic 
prescriptions in secondary care increased by 6.5% between 2012 and 2016, with an increase 
of 2.6% since 2015 [4].  
 
Antibiotic stewardship in hospitalized children presents a particular challenge. According to 
Gerber and co-workers, 60% of children may receive antibiotics during their hospitalization 
[5]. Not only are more children than adults prescribed antibiotics, but there have been 
fewer incentives to restrict antibiotic use in in children, for example to prevent Clostridium 
difficile infections. Another important consideration in paediatrics is parental expectations 
of antibiotic treatment for their children [6].  
 
The barriers to effective antibiotic stewardship are substantial and complex. In 2015, a 
Department of Health report identified that few studies have addressed behaviours that 
support antibiotic stewardship, and encouraged research in this field to contribute to the 
fight against antimicrobial resistance [7]. More recently a systematic review of antimicrobial 
stewardship programmes in children found there is limited evidence for a reduction in 
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antibiotic consumption and use of broad-spectrum/restricted agents following antibiotic 
stewardship programme implementation [8]. 
 
It is our opinion that a successful and sustainable antibiotic stewardship programme will 
require a bundle approach that addresses all the key processes involved in antibiotic 
prescribing [9]. However, whilst organisations such as the WHO [1], CDC [3] and the UK 
Department of Health [10] have published multi-point plans to address antibiotic 
stewardship, most research in antibiotic prescribing has focused on a single element, for 
example education-based interventions [11].  
 
In our study, we used a novel mixed methodology approach to investigate antibiotic 
prescribing behaviours. The aim was to identify the critical points in the antibiotic 
prescribing pathway for inpatients in a paediatric hospital. Specifically, we sought to 
understand the extent to which antibiotic prescribing decisions are driven by matters such 
as lack of knowledge, experience or empowerment of prescribers, organisational factors, 
suboptimal access to, or use of, laboratory tests, and factors relating to the built 
environment. Understanding all stages of the antibiotic prescribing pathway should identify 
the key elements that need to be included in an antibiotic prescribing bundle for children. 
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Methods 
Setting 
Birmingham Children’s Hospital is a 250-bed teaching hospital in the West Midlands (United 
Kingdom) that provides a wide range of secondary and tertiary paediatric services. The 
hospital has an onsite laboratory service (with online test requesting and results access) and 
an antibiotic pharmacist. There is no formal antimicrobial stewardship team outside routine 
working hours, but clinical teams can and do contact the on call microbiologist for 
antimicrobial prescribing advice. Medical records and drug prescriptions are paper-based. 
Antibiotic prescribing guidelines are available on the Trust intranet and via an app for Apple 
and Android users. Complex patients are treated across the hospital, and hence there is no 
restriction on use of broad spectrum antibiotics such as meropenem. However, a 
prescription of some antibiotics such as linezolid requires microbiology approval.  
 
The study 
The study was conducted in three phases. During Phase 1, a 20 item questionnaire was 
developed, which consisted of 9 demographic questions, 8 questions on prescribing 
behaviour and 3 scenario-based vignettes and open/closed questions. The aim was to 
develop a picture of the critical points in the pathway for antibiotic prescribing in the setting 
of a paediatric hospital. The questionnaire was piloted with staff from the hospital and the 
final version was distributed online through the hospital’s internal mailing list. In Phase 2, 
focus groups and individual interviews were held to explore prescribers’ views and 
experiences, in more depth. Phase 3 of the study was a 16 item questionnaire, which 
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included the same 9 demographic questions as Phase 1 and 7 open/closed questions to 
obtain opinions on possible solutions that were devised using the findings of Phases 1 and 2.  
 
The surveys used the Bristol Online Survey (BOS) platform (Jisc, Bristol, UK). Participation 
was anonymous and voluntary. The study was approved by the Aston University Research 
Ethics Committee (UREC).  
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Results  
Phase 1  
A total of 56 medical prescribers who regularly prescribed antibiotics completed the online 
survey. Of those, 25 participants had >10 years’, 16 participants had 6-10 years’ and 15 had 
≤5 years’ experience. 93% of prescribers were concerned about AMR and 64% were 
concerned about antibiotic related side effects.  
 
Twenty-two (39.3%) participants reported being pressurised into prescribing antibiotics that 
they did not think were necessary in the preceding 12 months (Table I). Such pressure 
mainly came from senior medical colleagues and patients’ families. There was a marked 
disparity between junior and senior staff with seventeen of the twenty-four (70.8%) junior 
staff reported having being pressurised compared with only five of thirty two (15.6%) 
consultants. The great majority (84%) of participants did not report that time constraints 
influenced their antibiotic prescribing (Figure 1). However, over half (59%) reported that 
laboratory factors were a regular barrier to antibiotic prescribing; the most common 
difficulty was results not being available when required. 
 
Approximately a quarter (26%) of participants either had never had any antibiotic training or 
could not recall when they last received training; 77.3% were consultants. A further 21.4% 
last received training more than three years ago.  However, only 23% of participants 
indicated they had a lack of antibiotic related training or knowledge; 80% of were junior 
prescribers.  40%, (n=27) of participants experienced a range of resource issues that 
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regularly (that is at least once a week) impacted on their decision whether or not to 
prescribe an antibiotic or to review an existing antibiotic prescription. The most common 
resource issue was inability to access antibiotic prescription guidelines.  
 
Clinical scenarios 
Scenario 1 was designed to assess prescribers’ abilities to interpret positive microbiology 
results that may not be significant (Figure 2). Only 8.9% of respondents were confident 
autonomously to not treat unexpected bacteriuria in an asymptomatic child with no pyuria. 
Scenario 2 tested prescribers’ willingness to prescribe narrow-spectrum antibiotics in a child 
with community-onset pneumonia, who was known to have gastrointestinal colonization 
with Extended Spectrum Beta Lactamase (ESBL) producing Escherichia coli (Figure 3). Almost 
half of prescribers were confident in selecting usual narrow spectrum antibiotics, although 
16.4% indicated that they would prescribe meropenem. Scenario 3 tested prescribers’ 
willingness to de-escalate antibiotic therapy in response to a positive microbiology result; 
only 5.5% were prepared to de-escalate broad-spectrum antibiotic therapy to benzyl 
penicillin to treat confirmed group A streptococcus sepsis (Figure 4). 
 
Phase 2 
Three main themes surfaced in the focus group discussions: despite concerns about AMR, 
prescribers did not associate continuing antibiotics for individual patients with a societal risk 
of antibiotic resistance; prescribers working out of hours were unwilling to change 
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antibiotics; prescribers of all grades reported they needed a clear decision-making 
mechanism to change current practice. 
 
Phase 3 
Phase 3 of the study was completed by 22 medical prescribers. Of those, 7 participants had 
>10 years’, 7 participants had 6-10 years’, and 8 participants had up to 5 years’ experience. 
Prescribers expressed a strong preference for direct instruction on antibiotic prescribing, 
rather than being given data upon which to base their own decisions. Professional advice 
was preferred to electronic support (Table IIa). Where prescribers were offered options for 
electronic support, they preferred didactic algorithms to any other solution (Table IIb). Most 
prescribers (95%) indicated that it would be useful to have a single direct access portal to 
access antibiotic prescribing advice; 12 (57%) favoured this being telephone-based, 7 
(33.3%) preferred an online system, and only 2 (9.5%) wanted a SMS-based system. Only a 
third of prescribers felt that they needed support on an out of hours basis. To obtain earlier 
laboratory results, respondents preferred these to be available on ward-based PCs; there 
was little support for the concept of dedicated electronic information points to access 
laboratory results (Table III). When asked about the content of any future training on 
antibiotic stewardship, prescribers indicated that a broad range of subjects needed to be 
covered (Table IV). 
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Discussion 
At least two of the five strategic objectives in the WHO Global Action Plan on Antimicrobial 
Resistance relate directly to the everyday prescribing practice, that is improving awareness 
and understanding of antimicrobial resistance through effective communication, education 
and training, and optimizing use of antimicrobials in human and animal health [1]. Likewise, 
the UK Five Year Antimicrobial Resistance Strategy includes objectives of optimising 
prescribing practice and improving professional education and training [10].  
 
In recent years, many papers have been published on measures to improve antibiotic 
stewardship. However, these have mostly addressed only one element underpinning 
antibiotic prescribing. Moreover, it has been noted that most antibiotic stewardship 
programmes have encountered significant barriers to success [12]. The challenge of 
successfully implementing an antibiotic stewardship campaign is underlined by our 
observation of the contradiction between prescribers’ understanding and practice. Whilst 
95% of prescribers responded that they were concerned about AMR, when their practice 
was tested in clinical vignettes, most of them were inclined to over treat with antibiotics. 
 
Education is widely held to be one of the cornerstones of antibiotic stewardship 
programmes [11, 13] and in England, the Health and Social Care Act requires that all 
prescribers receive induction and training in prudent antimicrobial use (14).  However, 
almost half the participants in our study did not recall receiving any training in at least the 
last three years. Given that the volunteer participants in the study were likely to be amongst 
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the most motivated of antibiotic prescribers, this was surprising. However, during the focus 
groups it became clear that most senior doctors did not perceive that they required further 
training on antibiotic stewardship.  
 
A recent review of antimicrobial stewardship training noted that although almost all studies 
of antibiotic stewardship training have reported positive results, there is a lack of rigorous 
evaluation of the true effectiveness of education programmes [15]. There is also no clarity 
on how training should be delivered. Although e-learning has become widely used as a 
means of delivering training on antibiotic stewardship [11], a recent Cochrane review of e-
learning for health professionals concluded that compared to traditional learning, e-learning 
may make little or no difference in patient outcomes or health professionals' behaviours, 
skills or knowledge [16]. Guidelines have identified that an extensive curriculum of antibiotic 
stewardship training is required, and our results show that prescribers themselves recognise 
that. 
 
It is possible that the lack of comprehensive education on antibiotic prescribing influenced 
participants’ responses to questions about the support they needed for antibiotic 
stewardship. Prescribers of all degrees of seniority expressed a strong preference for direct 
support in antibiotic decision making. Their preference was for professional support from an 
infection team member, which fits with the observations by Doernberg et al., that each 0.50 
increase in pharmacist and physician full-time equivalent support, predicted a 1.48-fold 
increase in the odds of demonstrating effectiveness of antibiotic stewardship programmes 
[15]. The preference for didactic support was also expressed when prescribers were asked 
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about IT-based solutions in more detail in phase 3, in that they preferred a support tool that 
gave instruction, rather than information to help them make their own decisions. This 
reflected the earlier opinions in the focus groups, that prescribers would be unwilling to 
change antibiotics on an out of hour’s basis, whatever support was available to them at that 
time. 
 
Prescribers expressed a very clear preference for the most expensive solution to antibiotic 
stewardship that is hiring additional specialists for support. However we speculate that one 
of the reasons for the negative attitude towards decision support tools in phase 3, may be 
that prescribers cannot envisage the degree of support that a properly designed tool may 
offer. Recognising this we propose future research on a support tool prototype.  
 
Prescribers were also critical of laboratory services, with around 25% of participants saying 
that delays in laboratory results reporting impacted on their antibiotic prescribing. The 
apparent dichotomy between prescribers’ unwillingness to take individual responsibility for 
actions in response to laboratory test results, and their desire for more rapid laboratory test 
results needs to be addressed in any support tool and  if new or improved rapid and/or 
point-of-care diagnostic tests are to become an effective element of stewardship strategies.  
 
The strength of our study is that it provides a comprehensive assessment of the experiences 
and opinions of a good number of medical antibiotic prescribers in a children’s hospital. 
Because most of the research team were unaffiliated to the hospital, it is likely that the 
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opinions expressed by participants were unbiased. However, this was a single centre study, 
performed in a specialist children’s hospital, where there are no IT-based solutions to 
antibiotic prescribing and there is no formal provision of an antibiotic stewardship team 
over the whole 24 hours, 7 days a week. As such, the findings of this study may not be 
generalizable to all hospital settings. 
 
Conclusions 
Our study showed that whilst there was general awareness of the importance of antibiotic 
stewardship, prescribers at all levels of seniority indicated that they lacked confidence to 
manage antibiotic treatment optimally. Whilst in the longer term a comprehensive 
education programme beginning at undergraduate level, and continuing throughout 
prescribers’ careers, may change antibiotic prescribing behaviours, our study suggests that 
in the shorter term, prescribers will require considerable support, preferably in the form of 
specialist personnel, if antibiotic stewardship goals are going to be met. 
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Table I:  Influences on prescribing antibiotics that the prescriber did not think were 
necessary (Respondents were permitted to select more than one option). 
 
Number (%) of 56 prescribers who indicated that they had been pressured into prescribing 
antibiotics that they did not think were necessary because of influence from: 
 
Senior 
Medical 
colleagues 
Medical 
colleagues 
at same 
grade as 
you Nurses 
The patient, 
or their 
carer/parents 
Time of 
day when 
you are 
prescribing Other 
I have not 
experienced 
this 
12 (21.4) 3 (5.4) 1 (1.8) 9 (16.1) 5 (8.9) 4 (7.1) 34 (60.7) 
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Table IIa: Ranking of factors that may provide prescribers with reassurance that it is safe 
to stop or change an antibiotic prescription on the basis of preliminary microbiology 
results (1 = most confidence, 3 = least confidence) 
Factors Number (%) of responses 
1 2 3 
Daily report of the progress of 
laboratory tests  
8 (36.4) 5 (22.7) 9 (40.9) 
Electronic guidance in addition to 
daily reports of the progress of 
laboratory tests 
2 (9.1) 8 (36.4) 12 (54.5) 
Antibiotic professional support in 
addition to the daily reports of the 
progress of laboratory tests  
12 (54.5) 5 (22.7) 5 (22.7) 
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Table IIb: If a tool was available to guide your antibiotic prescribing decisions (either 
before or after preliminary microbiology results were available) which of the following 
would give you confidence to use this tool? Please rank the options (1 = most confidence, 
3 = least confidence)  
 
Format of decision making tools Number (%) of responses 
1 2 3 
An algorithm to aid appropriate 
antibiotic prescription,  based on  
risk factors for antibiotic resistance  
in the individual patient 
18 (81.8) 3 (13.6) 1 (4.5) 
Statistical data to allow you to 
understand the likelihood of patients 
having infection with antibiotic-
resistant bacteria. This might include 
data showing the overall risk of any 
patient having infection with an 
antibiotic-resistant bacterium, &/or 
the risk of a patient colonised with an 
antibiotic-resistant bacterium 
becoming infected with the same 
organism 
3 (13.6) 11 (50) 8 (36.4) 
Data on how similar patients were 
treated, and their outcomes 
1 (4.5) 8 (36.4) 13 (59.1) 
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Table III:  Ranking of electronic means of delivery of early laboratory results (1 = most 
preferred, 3 = least preferred)  
Electronic format  Number (%) of responses 
1 2 3 
Portable electronic devices  
 
4 (19) 14 (66.7) 3 (14.3) 
Dedicated electronic information 
points 
4 (19) 5  (23.8) 12 (57.1) 
Availability on the ward PC to check 
results 
13 (61.9) 2  (9.5) 6 (28.6) 
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 Table IV: Which of the following do you think antibiotic training and education should 
cover? Please tick all of the options which apply. 
Option n 
Data relating to antibiotic resistance at the local, regional, national and 
international level 
18 
Risks of inappropriate antibiotic use 19 
Wider impact of individual antibiotic prescribing decisions for example the 
risk to other patients from commencing a patient on broad spectrum 
antibiotics 
19 
Factors which guide reviewing and stopping antibiotic treatment 20  
Factors which guide antibiotic prescribing decisions  21 
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0 5 10 15 20 25
Other (please state)
Backlog of samples to be processed in the laboratory
Poor communication within the Ward or Department
Laboratory computer system is too slow or cumbersome
Timely delivery of the samples to the laboratory
Pressure from either by colleagues or
patients/parents/carers
Laboratory results not ready when I need them
Number of reponses 
0 5 10 15 20 25
Disregard result
Prescribe antibiotics
Reassess patient clinically
Obtain repeat urine sample
Discuss results with microbiology or other specialist
Number of responses 
Figure 1: laboratory factors influencing antibiotic prescribing 
 
 
 
Figure 2: responses to clinical scenario 1 (patient with unexpected asymptomatic 
bacteriuria) 
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0 5 10 15 20 25
Amoxicillin, because that is the first-line treatment for
community-acquired pneumonia
Co-amoxiclav, because this child has a history of previous
hospital admissions and you are not confident that…
Co-amoxiclav + gentamicin, because gentamicin will
probably provide cover for the E. coli
Meropenem, because that will definitely cover the E. coli
Discuss results with microbiology or other specialist
Obtain further clinical information  before deciding
Number of responses 
Figure 3: responses to clinical scenario 2 (patient with community acquired pneumonia 
and carriage of ESBL producing E.coli) 
 
 
 
 
Figure 4: responses to clinical scenario 3 (patient with Group A streptococcus) 
 
 
0 2 4 6 8 10 12 14 16 18 20
Continue the current treatment because the child is
getting  better
Stop the vancomycin, because meropenem alone should
be adequate
Switch the child to benzylpenicillin, which will cover the
group A streptococcus, but will not give broad-spectrum
cover
Discuss results with microbiology or other specialist
Number of responses
